SLC39A7 and breast carcinoma: Similarly, ZIP7 was significantly upregulated in breast cancer, consistent with its known role in promoting proliferative signalling through zinc-mediated activation; however, no significant difference in ZIP7 expression was observed in colorectal cancer.